Table 1.
Comparison of the laboratory data at baseline and SVR24
Normal range | Baseline, March 4, 2015 | SVR24, April 13, 2016 | |
---|---|---|---|
HCV genotype |
not detected |
1b |
|
Level of HCV RNA, log IU/ml | not detected | 6.3 | |
Anti-HCV | negative | positive | |
Anti-HBc | negative | positive | |
HBsAg | negative | negative | |
Existence of DCV-resistant NS5A-L31M | not detected | wild type | |
Existence of DCV-resistant NS5A-Y93 | not detected | wild type | |
AST, U/I | 13–33 | 37 | 23 |
ALT, U/I | 6–27 | 25 | 12 |
ALP, U/l | l19–229 | 251 | 260 |
Gamma GTP, U/l | 10–47 | 18 | 13 |
T.Bil, mg/dl | 0.2–l.5 | 0.6 | 0.7 |
D.Bil, mg/dl | 0.1–0.4 | 0.2 | 0.2 |
T.pro, g/dl | 6.7–8.3 | 8.1 | 7.7 |
Alb, g/dl | 4.0–5.0 | 4.4 | 4.1 |
T.cho, mg/dl | 128–256 | 233 | 252 |
BUN, mg/dl | 8–22 | 13 | 14 |
Crea, mg/dl | 0.4–0.7 | 0.55 | 0.61 |
Na, nmol/l | 138–146 | 140 | 139 |
K, nmol/l | 3.6–4.9 | 4.0 | 4.3 |
Cl, nmol/l | 99–109 | 103 | 103 |
AFP, ng/ml | <10.0 | 3.2 | 2.2 |
PIVKAII, mAU/ml | 0–28 | 21 | 28 |
RBC, ×104/µl | 375–514 | 464 | 443 |
Hb, g/dl | 10.6–15.4 | 14.4 | 13.6 |
WBC, µl | 3,500–9,500 | 3,400 | 4,700 |
Plt, x104/µl | 16.4–37.6 | 21.4 | 20.9 |
HbA1c, % | 4.6–6.2 | 5.6 | 5.6 |
SVR = Sustained virological response; Anti-HCV = anti-HCV antibody; Anti-HBc = anti-hepatitis B core antibody; HBsAg = hepatitis B surface antigen; AST = aspartate aminotransferase; ALT = alanine aminotransferase M; ALP = serum alanine aminotransferase; gamma GTP = gamma glutamyl transpeptidase; T.Bil = total bilirubin; D.Bil = direct bilirubin; T.pro = total protein; Alb = albumin; T.cho = total cholesterol; BUN = blood urea nitrogen; Crea = creatinine; Na = sodium; K = potassium; Cl = chloride; AFP = alpha fetoprotein; PIVKAII = protein induced by vitamin K absence or antagonists-II; RBC = red blood cell; Hb = hemoglobin; WBC = white blood cell; PLT = platelets; HbA1c = hemoglobin A1c.